EI
NKTR icon

EFG International’s Nektar Therapeutics NKTR Stock Holding History

EFG International’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$3.17K – 1085
2025
Q4 		$3.17K Buy
+75
New +$4.2K ﹤0.01% 838

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EFG International's NKTR Position: Q1 2026 in Review

EFG International sold out of Nektar Therapeutics (NKTR) in Q1 2026, closing a stake of 75 shares — an estimated $3.17K sold.

EFG International first reported a position in NKTR in Q4 2025 and held it in 1 quarter. The position peaked at $3.17K in Q4 2025. 216 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • EFG International reported no remaining Nektar Therapeutics position as of Q1 2026 after selling out during the quarter.
  • EFG International sold 75 Nektar Therapeutics shares in Q1 2026, an estimated $3.17K.
  • EFG International first reported a position in Nektar Therapeutics in Q4 2025 and held it in 1 quarter.
  • EFG International's Nektar Therapeutics position peaked at $3.17K in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.